Proteona leads international consortium to develop SARS-CoV-2 neutralizing antibody to help vulnerable immunocompromised individuals Innovative AI-driven proteogenomic analysis company applies single cell analysis expertise to developing treatments for COVID-19 The Proteona team is leveraging on its ESCAPE™ single cell proteogenomics platform to discover SARS-CoV-2 neutralizing antibodies. Singapore, 25 March 2020 – Proteona Pte. Ltd. and partners […]

DUBLIN and TAMPA, Florida, — Avectas, a cell engineering technology business and Vycellix, Inc. an immuno-discovery cell & gene therapy company, today announced that the companies have entered into a collaboration agreement to develop proprietary approaches for cell-based immunotherapeutic products. The companies will collaborate on the delivery of Vycellix’s novel RNA immunomodulator VY-M using Avectas’ […]

CELLvo™ Matrix Plus is a novel extracellular matrix derived from human cells that improves relevancy of cell culture studies The new cell culture substrate from StemBioSys supports isolation and culture of various cell types, including pluripotent cells. SAN ANTONIO, TX, March 24, 2020 – CELLvo™ Matrix Plus, a new extracellular matrix product from StemBioSys, Inc., […]

Capabilities and capacity now available to help customers of all sizes meet increasing demand for new biologics, cell and gene therapies, and drug products NEEDHAM, Mass. — For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and […]

Company Builds Leadership Team for Next Stage of Growth with Expanded Commercialization of Organs-on-Chips Product Suite BOSTON, Mass. – March 19, 2020 – Emulate, Inc., today announced that Jim Corbett has been appointed as Chief Executive Officer and Martin Madaus, Ph.D., has been appointed Executive Chairman of the company’s Board of Directors. These life science […]

BOSTON, Mass. — Emulate, Inc. today announced that the company has completed the 150th installation of its Zoë® instrument, part of a lab-ready platform for Organs-on-Chips technology for use by researchers across many industries, particularly with early adopters conducting R&D related to drug discovery and development. Emulate has expanded its portfolio of commercially available Zoë-compatible […]

Beckman Coulter Life Sciences Revolutionizes Nanoparticle Analysis, Enabling Characterization Down To 40 nm With Launch of CytoFLEX nano Flow Cytometer Instrument Breaks the Boundaries of EV Detection, Providing Access to New Data Points INDIANAPOLIS, USA − Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation and a subsidiary of Danaher Corporation (NYSE: DHR), […]

Alameda, CA – Fluxion Biosciences, the leading developer of live cell analysis systems that feature physiological shear flow, has just announced the release of BioFlux One, its most affordable BioFlux system. The BioFlux One system is the solution for labs that run flow cell experiments but don’t need 2-phase flow. It provides all the benefits […]

(UPM, Helsinki) – UPM Biomedicals and Nichirei Biosciences Inc. signed an agreement on 1 March 2020 to offer the full range of UPM cell culture products to life sciences researchers in Japan. This agreement will provide the country’s cell biology community with direct access to UPM’s GrowDex® hydrogels for the first time, supporting advanced cell […]

LEIDEN, The Netherlands — Toxys is an innovative Dutch biotech company that develops unique animal-free laboratory tests for the safety assessment of novel medicines, chemicals, cosmetics and food. Today, Toxys announces a €2 million funding round from KIKK Capital, InnovationQuarter, Zeeland Investment fund, Toxys management and Rabobank. This investment is being made to advance Toxys’ ambition to become the global […]